Trilogy Capital’s Chimera Investment CIM Stock Holding History

Trilogy Capital’s Portfolio CIM Stock Details CIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,500	Closed	-$187K	–	129
2018 Q4	$187K	Sell	3,500 -26	-0.7%	-$1.42K	0.03%	122
2018 Q3	$192K	Buy	+3,526	New	+$198K	0.02%	145

Other funds holding CIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

CLG

Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WFI

West Family Investments Carlsbad, California $345M AUM 46.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trilogy Capital's CIM Position: Q1 2019 in Review

Trilogy Capital sold out of Chimera Investment (CIM) in Q1 2019, closing a stake of 3,500 shares — an estimated $187K sold.

Trilogy Capital first reported a position in CIM in Q3 2018 and held it in 2 quarters. The position peaked at $192K in Q3 2018. 273 funds tracked by Wall St. Rank hold CIM as of Q1 2019.

Trilogy Capital reported no remaining Chimera Investment position as of Q1 2019 after selling out during the quarter.
Trilogy Capital sold 3,500 Chimera Investment shares in Q1 2019, an estimated $187K.
Trilogy Capital first reported a position in Chimera Investment in Q3 2018 and held it in 2 quarters.
Trilogy Capital's Chimera Investment position peaked at $192K in Q3 2018.
273 funds tracked by Wall St. Rank held Chimera Investment as of Q1 2019.

Based on Trilogy Capital's 13F filing for Q1 2019, filed 17 Apr 2019.